Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Intrinsic factor
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== Treatment === In most countries, [[intramuscular injection]]s of vitamin B<sub>12</sub> are used to treat [[pernicious anemia]].<ref name="Shipton_2015" /> Orally administered vitamin B<sub>12</sub> is absorbed without intrinsic factor, but at levels of less than one percent than if intrinsic factor is present.<ref>{{cite journal | vauthors = Alpers DH | title = What is new in vitamin B(12)? | journal = Current Opinion in Gastroenterology | volume = 21 | issue = 2 | pages = 183β186 | date = Mar 2005 | pmid = 15711210 | doi = 10.1097/01.mog.0000148331.96932.44 | department = (review) }}</ref> Despite the low amounts absorbed, oral vitamin B<sub>12</sub> therapy is effective at reducing symptoms of pernicious anemia.<ref name="Andres_2010">{{cite journal | vauthors = AndrΓ¨s E, Fothergill H, Mecili M | title = Efficacy of oral cobalamin (vitamin B12) therapy | journal = Expert Opinion on Pharmacotherapy | volume = 11 | issue = 2 | pages = 249β256 | date = Feb 2010 | pmid = 20088746 | doi = 10.1517/14656560903456053 | s2cid = 37088496 | department = (review) }}</ref> Vitamin B<sub>12</sub> can also be given [[sublingual administration|sublingually]], but there is no evidence that this route of administration is superior to the oral route,<ref name="Sharabi_2003">{{cite journal | vauthors = Sharabi A, Cohen E, Sulkes J, Garty M | title = Replacement therapy for vitamin B12 deficiency: comparison between the sublingual and oral route | journal = British Journal of Clinical Pharmacology | volume = 56 | issue = 6 | pages = 635β638 | date = Dec 2003 | pmid = 14616423 | pmc = 1884303 | doi = 10.1046/j.1365-2125.2003.01907.x | department = (primary) }}</ref> and only Canada and Sweden routinely prescribe this route of administration.<ref name="Shipton_2015">{{cite journal | vauthors = Shipton MJ, Thachil J | title = Vitamin B12 deficiency - A 21st century perspective | journal = Clinical Medicine | location = London, England | volume = 15 | issue = 2 | pages = 145β150 | date = Apr 2015 | pmid = 25824066 | pmc = 4953733 | doi = 10.7861/clinmedicine.15-2-145 | department = (review) }}</ref> Because vitamin B<sub>12</sub> absorption is a multistep process that involves the stomach, pancreas and small intestine, and is mediated by two carriers: [[Haptocorrin]] and intrinsic factor, and because [[Haptocorrin]] ([[Transcobalamin|transcobalamin I]]) binds to vitamin B<sub>12</sub>, and Vitamin B<sub>12</sub> is acid-sensitive, when vitamin B<sub>12</sub> binds to [[Haptocorrin]] it can safely pass through the acidic stomach to the duodenum, given time in the mouth.<ref name="Fedosov_2012" />
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)